Stem Cell Therapy Co. Hit With $5.1M Deceptive Ad Judgment

By Rachel Scharf · January 9, 2025, 5:58 PM EST

A Georgia federal judge has ordered a stem cell therapy company and its co-founders to pay the state $5.1 million for falsely marketing its product as a cure-all miracle treatment for...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

Federal Trade Commission et al v. Peyroux et al

Case Number

Court

Georgia Northern

Nature of Suit

Other Statutory Actions

Date Filed

August 16, 2021

Recent Articles By Rachel

January 10, 2025
Social Media Apps Fail To Trim Calif. Mental Health Mass Tort
January 09, 2025
Biden's Title IX Gender Identity Rule Struck By Ky. Judge
December 17, 2024
Express Scripts, OptumRx Can't Ditch LA County Opioid Suit
December 10, 2024
Md. Jury Convicts Ex-Biotech Execs On Some Fraud Counts
December 03, 2024
J&J's Neosporin Forever Discolored Man's Groin, Suit Says
November 15, 2024
HHS Likely To Limit Migrant Data After Flores Deal Ends
November 12, 2024
Elanco Pays $15M SEC Fine To Settle Sales Incentive Claims
November 08, 2024
9th Circ. Doubts Weight Loss Doc's Fraud Conviction Appeal
November 07, 2024
Calif. Gov. Lays Groundwork To Fight Trump Policies In Court
October 31, 2024
CVS Unit Exec's Ex-Partner Charged With Insider Trading